Gyre Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 1,267,092 | 1.36% |
Individual Insiders | 5,785,119 | 6.19% |
General Public | 22,366,086 | 23.9% |
Public Companies | 64,005,887 | 68.5% |
Dilution of Shares: GYRE only recently listed within the past 12 months
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
64,005,887 | US$876.2m | 0% | no data | |||
2,942,467 | US$40.3m | 0% | no data | |||
2,840,376 | US$38.9m | 0% | no data | |||
499,489 | US$6.8m | 191% | no data | |||
259,807 | US$3.6m | 61.8% | no data | |||
231,641 | US$3.2m | 18.7% | no data | |||
96,078 | US$1.3m | 137% | no data | |||
32,700 | US$447.6k | 35.9% | no data | |||
23,091 | US$316.2k | 247% | no data | |||
18,467 | US$252.9k | 0% | 0.02% | |||
18,266 | US$250.0k | 0% | no data | |||
13,900 | US$190.3k | 0% | no data | |||
10,720 | US$146.7k | -58% | no data | |||
10,291 | US$140.9k | 0% | no data | |||
10,200 | US$139.7k | 0% | no data | |||
7,251 | US$99.2k | 27.1% | no data | |||
4,969 | US$68.0k | 0% | no data | |||
3,959 | US$54.2k | 34.7% | no data | |||
3,752 | US$51.4k | 0% | no data | |||
2,987 | US$40.9k | 3,010% | no data | |||
2,972 | US$40.7k | 0% | no data | |||
2,433 | US$33.3k | 0% | no data | |||
2,276 | US$31.2k | 0% | no data | |||
2,123 | US$29.0k | 0% | no data | |||
1,562 | US$21.4k | -87.2% | no data |